Final guidance from NICE on Merck, Pfizer’s Bavencio

12th April 2018 Uncategorised 0

The National Institute for Health and Care Excellence has now published final guidelines endorsing Merck and Pfizer’s Bavencio as an option for patients with Merkel cell carcinoma (MCC).

More: Final guidance from NICE on Merck, Pfizer’s Bavencio
Source: News